000 | 01949 a2200469 4500 | ||
---|---|---|---|
005 | 20250515023713.0 | ||
264 | 0 | _c20060619 | |
008 | 200606s 0 0 eng d | ||
022 | _a1198-743X | ||
024 | 7 |
_a10.1111/j.1469-0691.2006.01389.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRodríguez-Martínez, J M | |
245 | 0 | 0 |
_aCorrelation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids. _h[electronic resource] |
260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cMay 2006 |
||
300 |
_a440-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
650 | 0 | 4 |
_aAza Compounds _xpharmacology |
650 | 0 | 4 |
_aBacterial Proteins _xbiosynthesis |
650 | 0 | 4 | _aBlotting, Northern |
650 | 0 | 4 | _aBlotting, Southern |
650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
650 | 0 | 4 | _aConjugation, Genetic |
650 | 0 | 4 |
_aDNA, Bacterial _xchemistry |
650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
650 | 0 | 4 |
_aEscherichia coli _xgenetics |
650 | 0 | 4 | _aFluoroquinolones |
650 | 0 | 4 | _aGene Dosage |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKlebsiella Infections _xmicrobiology |
650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
650 | 0 | 4 | _aMoxifloxacin |
650 | 0 | 4 |
_aPlasmids _xgenetics |
650 | 0 | 4 |
_aQuinolines _xpharmacology |
700 | 1 | _aVelasco, C | |
700 | 1 | _aPascual, A | |
700 | 1 | _aGarcía, I | |
700 | 1 | _aMartínez-Martínez, L | |
773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 12 _gno. 5 _gp. 440-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1469-0691.2006.01389.x _zAvailable from publisher's website |
999 |
_c16246205 _d16246205 |